Ezlopitant | MedChemExpress (MCE)
Ezlopitant (CJ-11,974) is a selective, non-peptidic neurokinin-1 (NK-1)-receptor antagonist. Ezlopitant inhibits both acute and delayed emetic reactions induced by Cisplatin (HY-17394) in ferrets via acting on NK1 receptors in the central nervous system. Ezlopitant has the potential for pain, chemotherapy-induced emesis and irritable bowel syndrome research[1][2][3].
| Trivial name | Ezlopitant |
| Catalog Number | HY-106982 |
| Alternative Name(s) | CJ-11,974 |
| Research Area | Neurological Disease; Metabolic Disease |
| CAS# | 147116-64-1 |
| Purity | ≥98.0% |
| SMILES | COC(C=CC(C(C)C)=C1)=C1CN[C@@H](C2CCN3CC2)[C@@H]3C(C4=CC=CC=C4)C5=CC=CC=C5 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/ezlopitant.html |